FMR LLC 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 10:59 am Sale | 2023-02-09 | 13G | Global Blood Therapeutics, Inc. GBT | FMR LLC | 278,419 0.410% | -4,318,972 (-93.94%) | Filing |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Global Blood Therapeutics, Inc. GBT | FMR LLC | 4,597,391 7.099% | 3,370,553 (+274.73%) | Filing |
| 2021-05-10 1:11 pm Sale | 2021-05-07 | 13G | Global Blood Therapeutics, Inc. GBT | FMR LLC | 1,226,838 1.970% | -3,180,227 (-72.16%) | Filing |
| 2021-02-08 10:23 am Sale | 2021-02-05 | 13G | Global Blood Therapeutics, Inc. GBT | FMR LLC | 4,407,065 7.131% | -2,244,230 (-33.74%) | Filing |